2-(4-Hydroxycarbonyl-2-nitrophenyl)malondialdehyde, 95.0%, 25g

3-Bromo-4-fluorobenzamidoxime, 90.0%, 5g

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromo-1H-indol-3-yl)propanoic acid, 98%, 25g

(4R,4'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 100mg

3-VINYLOXETAN-3-OL, 95.0%, 1g

1,2,5,6-Tetrabromocyclooctane, 95%, 1g

((3-Bromo-2-methylpropoxy)methyl)benzene, 95.0%, 250mg

Methyl 2-(4-bromo-6-methylpyridin-2-yl)acetate, 95%, 5g

2-(Trifluoromethyl)nicotinic acid, 97.0%, 100g

Methyl 2,3-dihydroxybenzoate, 95.0%, 100g

3H,4H-pyrrolo[1,2-d][1,2,4]triazin-4-one, 98%, 1g

1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, 99.0%, 25g

3-Ethyl-1-methyl-1H-imidazol-3-ium Dimethyl Phosphate>98.0%(HPLC)(T)5g